News

PromarkerD showcased at American Diabetes Association conference 2019

Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) was invited to feature on the American Diabetes Association (ADA) TV News Network as a key opinion leader (KOL) on diabetic kidney disease diagnostics, which includes an update on PromarkerD, during the ADA 79th Scientific Sessions conference (San Francisco, June 7-11, 2019).

Proteomics International Managing Director Dr Richard Lipscombe outlines the impact PromarkerD will have saving lives and healthcare costs, and the global roll-out plans for PromarkerD in the exclusive interview to be broadcast at the industry’s leading conference.

Watch PromarkerD featured on ADATV: Learn more

Proteomics International biostatistician Dr Kirsten Peters (left) with licence partners Patia Biopharma general director Rodrigo Sierra (centre) and medical director Dr Jessica Otero (right)

 

Dr. Richard Lipscombe (left) with Mr. Chuck Morrison (right) at ADA 2019

 

Subscribe
  • This field is for validation purposes and should be left unchanged.